The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
A Critical Interaction between NR2B and MAGUK in l-DOPA Induced Dyskinesia
Open accessAbstract
Abnormal function of NMDA receptor has been suggested to be correlated with the pathogenesis of Parkinson’s disease (PD) as well as with the development of l-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesia. Here we show that NMDA receptor NR2 subunits display specific alterations of their subcellular distribution in striata from unilateral 6-hydroxydopamine-lesioned,l-DOPA-treated dyskinetic, and l-DOPA-treated nondyskinetic rats. Dyskinetic animals have significantly higher levels of NR2A subunit in the postsynaptic compartment than all other experimental groups, whereas NR2B subunit shows a significant reduction in both dopamine-denervated and dyskinetic rats. These events are paralleled by profound modifications of NMDA receptor NR2B subunit association with interacting elements, i.e., members of the membrane-associated guanylate kinase (MAGUK) protein family postsynaptic density-95, synapse-associated protein-97 and synapse-associated protein-102. Treatment of nondyskinetic animals with a synthetic peptide (TAT2B) able to affect NR2B binding to MAGUK proteins as well as synaptic localization of this subunit in nondyskinetic rats was sufficient to induce a shift of treated rats toward a dyskinetic motor behavior. These data indicate abnormal NR2B redistribution between synaptic and extrasynaptic membranes as an important molecular disturbance of the glutamatergic synapse involved in l-DOPA-induced dyskinesia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
PDZ domain proteins of synapses
Kim, E., & Sheng, M. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1517 · Cited by 1,577
Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 1,371
Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions
Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y.-T., Salter, M. W., & Tymianski, M. (2002) · Science · doi:10.1126/science.1072873 · Cited by 999
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821
Self-citationSCHWARTING, R., & HUSTON, J. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00040-8 · Cited by 737
Lundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N., & Cenci, M. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01843.x · Cited by 664
Cenci, M. A., Lee, C. S., & Björklund, A. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00285.x · Cited by 641
Levodopa motor complications in Parkinson's disease
Obeso, J. A., Olanow, C. W., & Nutt, J. G. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00031-8 · Cited by 478
Strack, S., & Colbran, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.20689 · Cited by 443
Mobile NMDA Receptors at Hippocampal Synapses
Tovar, K. R., & Westbrook, G. L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00658-x · Cited by 431
Dunah, A. W., & Standaert, D. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05546.2001 · Cited by 373
Molecular organization of the postsynaptic specialization
Sheng, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111146298 · Cited by 336
NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex
Sans, N., Prybylowski, K., Petralia, R. S., Chang, K., Wang, Y.-X., Racca, C., Vicini, S., & Wenthold, R. J. (2003) · Nature Cell Biology · doi:10.1038/ncb990 · Cited by 327
Omkumar, R. V., Kiely, M. J., Rosenstein, A. J., Min, K.-T., & Kennedy, M. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31670 · Cited by 304 · cited 7×
“The following antibodies were used: mouse ␣CaMKII antibody and polyclonal GluR1, NR2A, and NR2B antibodies were purchased from Chemicon (Temecula, CA).”
BackgroundInfluentialDunah, A. W., Wang, Y., Yasuda, R. P., Kameyama, K., Huganir, R. L., Wolfe, B. B., & Standaert, D. G. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23206-5 · Cited by 263
Hallett, P. J., Dunah, A. W., Ravenscroft, P., Zhou, S., Bezard, E., Crossman, A. R., Brotchie, J. M., & Standaert, D. G. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.008 · Cited by 192
Gardoni, F., Caputi, A., Cimino, M., Pastorino, L., Cattabeni, F., & Di Luca, M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041733.x · Cited by 187
Self-citationGardoni, F., Schrama, L. H., Kamal, A., Gispen, W. H., Cattabeni, F., & Di Luca, M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01501.2001 · Cited by 174
Self-citationPicconi, B., Gardoni, F., Centonze, D., Mauceri, D., Cenci, M. A., Bernardi, G., Calabresi, P., & Luca, M. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1224-04.2004 · Cited by 160
Self-citationTahar, A. H., Grégoire, L., Dare, A., Bélanger, N., Meltzer, L. T., & Bédard, P. J. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.10.007 · Cited by 141
N-Methyl-D-aspartate Receptors: Subunit Assembly and Trafficking to the Synapse
Prybylowski, K., & Wenthold, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r300029200 · Cited by 137
Antiparkinsonian Actions of Ifenprodil in the MPTP-Lesioned Marmoset Model of Parkinson's Disease
Nash, J. E., Fox, S. H., Henry, B., Hill, M. P., Peggs, D., McGuire, S., Maneuf, Y. P., Hille, C. J., Brotchie, J. M., & Crossman, A. R. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7444 · Cited by 127
Oh, J. D., Vaughan, C. L., & Chase, T. N. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01121-x · Cited by 124
CaMKII-dependent Phosphorylation Regulates SAP97/NR2A Interaction
Gardoni, F., Mauceri, D., Fiorentini, C., Bellone, C., Missale, C., Cattabeni, F., & Luca, M. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303576200 · Cited by 124
Self-citationLöschmann, P. A., de Groote, C., Smith, L. A., Wüllner, U., Fischer, G., Kemp, J. A., Jenner, P. G., & Klockgether, T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.018 · Cited by 103
Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions
Menegoz, M., Lau, L., Hervé, D., Huganir, R. L., & Girault, J. (1995) · Neuroreport · doi:10.1097/00001756-199512290-00030 · Cited by 99
Nash, J. E., Ravenscroft, P., McGuire, S., Crossman, A. R., Menniti, F. S., & Brotchie, J. M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.004 · Cited by 94
Nash, J. E., Johnston, T. H., Collingridge, G. L., Garner, C. C., & Brotchie, J. M. (2005) · The FASEB Journal · doi:10.1096/fj.04-1854fje · Cited by 91
Lim, I. A., Merrill, M. A., Chen, Y., & Hell, J. W. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00276-4 · Cited by 89
Wessell, R., Ahmed, S. M., Menniti, F. S., Dunbar, G. L., Chase, T. N., & Oh, J. D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.03.011 · Cited by 84
The NMDA Receptor Complex Is Altered in an Animal Model of Human Cerebral Heterotopia
Gardoni, F., Pagliardini, S., Setola, V., Bassanini, S., Cattabeni, F., Battaglia, G. S., & Luca, M. D. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.6.662 · Cited by 35
Self-citation
Cited by
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Functional Neuroanatomy of the Basal Ganglia
Lanciego, J. L., Luquin, N., & Obeso, J. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009621 · Cited by 833
Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
Obeso, J. A., Rodríguez-Oroz, M. C., Benitez-Temino, B., Blesa, F. J., Guridi, J., Marin, C., & Rodriguez, M. (2008) · Movement Disorders · doi:10.1002/mds.22062 · Cited by 663
Olanow, C. W., Obeso, J. A., & Stocchi, F. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70521-x · Cited by 547
Metadata
- Authors
- Gardoni, F., Picconi, B., Ghiglieri, V., Polli, F., Bagetta, V., Bernardi, G., Cattabeni, F., Di Luca, M., & Calabresi, P.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-03-15
- Volume
- 26
- Issue
- 11
- Pages
- 2914-2922
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1994911797
- Cited by
- 269
- References
- 34
- FWCI
- 11.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.